Waghmare Prajakta H, Huang Chien-Yu, Jaynes Heather A, Green Wendy M, Snyder Margie E, Adeoye-Olatunde Omolola A, Coe Antoinette B, Farley Joel F, Zillich Alan J
J Am Pharm Assoc (2003). 2023 Mar-Apr;63(2):538-546.e2. doi: 10.1016/j.japh.2022.10.021. Epub 2022 Oct 22.
Medication synchronization (med-sync) aligns patients' monthly or quarterly chronic medications to a predetermined single pickup date at a community pharmacy. The study objective was to examine med-sync enrollment disparities based on Medicare beneficiaries' predisposing, enabling, and need characteristics.
This was a retrospective cohort study using a Medicare dataset of beneficiaries receiving medications from pharmacies that self-identified as providing med-sync. Medicare beneficiaries who were continuously enrolled in fee-for-service medical and pharmacy benefits during the study period (2014-2016) were included. Study cohorts (med-sync and non-med-sync patients) were defined, and bivariate and multivariable logistic regression analyses were performed. Andersen's Health Services Utilization Model guided our inclusion of predisposing, enabling, and need characteristics to examine for association with med-sync enrollment.
A total of 170,180 beneficiaries were included, of which 13,193 comprised the med-sync cohort and 156,987 comprised the non-med-sync cohort. Bivariate logistic regression analysis revealed statistically significant differences (P < 0.05) in cohorts based on age, geographic region, type of residence, number of unique chronic medications, comorbidities, outpatient visits, and inpatient hospitalizations. Beneficiaries had higher odds of being enrolled in med-sync with increasing age (adjusted odds ratio [AOR] 1.003 [95% CI 1.001-1.005]) and if they resided in the Northeast (AOR 1.094 [95% CI 1.018-1.175]), South (AOR 1.109 [95% CI 1.035-1.188]), and West (AOR 1.113 [95% CI 1.020-1.215]) than those in the Midwest. Beneficiaries residing in nonmetro areas had lower odds of enrollment (AOR 0.914 [95% CI 0.863-0.969]) than those in metro areas. Beneficiaries with previous fewer inpatient hospitalizations (AOR 0.945 [95% CI 0.914-0.977]) were more likely to be enrolled, and those with more outpatient visits (AOR 1.003 [95% CI 1.001-1.004]) were more likely to be enrolled. Those taking a higher number of oral chronic medications (AOR 1.005 [95% CI 1.002-1.008]) had greater odds of enrollment in med-sync.
Med-sync program expansion opportunities exist to address potential enrollment disparities based on age, geographic region, metropolitan area, and prior health utilization. Further studies are needed to develop and examine strategies among pharmacies to improve med-sync enrollment outreach to these subgroups of patients.
药物同步服务(med-sync)将患者每月或每季度的慢性药物调配至社区药房预先确定的单一取药日期。本研究的目的是根据医疗保险受益人的易患因素、促成因素和需求特征,研究药物同步服务登记的差异。
这是一项回顾性队列研究,使用了医疗保险数据集,该数据集来自那些自我认定提供药物同步服务的药房的受益人。纳入了在研究期间(2014 - 2016年)持续参保按服务收费的医疗和药房福利的医疗保险受益人。定义了研究队列(药物同步服务组和非药物同步服务组患者),并进行了双变量和多变量逻辑回归分析。安德森健康服务利用模型指导我们纳入易患因素、促成因素和需求特征,以检验与药物同步服务登记的关联。
总共纳入了170180名受益人,其中13193名构成药物同步服务队列,156987名构成非药物同步服务队列。双变量逻辑回归分析显示,基于年龄、地理区域、居住类型、独特慢性药物数量、合并症、门诊就诊次数和住院次数,队列之间存在统计学显著差异(P < 0.05)。受益人年龄越大(调整后的优势比[AOR]为1.003 [95%置信区间1.001 - 1.005]),以及居住在东北部(AOR为1.094 [95%置信区间1.018 - 1.175])、南部(AOR为1.109 [95%置信区间1.035 - 1.188])和西部(AOR为1.113 [95%置信区间1.020 - 1.215])的人比居住在中西部的人参与药物同步服务的几率更高。居住在非都市地区的受益人参与登记的几率(AOR为0.914 [95%置信区间0.863 - 0.969])低于居住在都市地区的人。以前住院次数较少的受益人(AOR为0.945 [95%置信区间0.914 - 0.977])更有可能参与登记,而门诊就诊次数较多的人(AOR为1.003 [95%置信区间1.001 - 1.004])更有可能参与登记。服用口服慢性药物数量较多的人(AOR为1.005 [95%置信区间1.002 - 1.008])参与药物同步服务的几率更大。
存在药物同步服务项目扩展机会,以解决基于年龄、地理区域、都市地区和既往健康利用情况的潜在登记差异。需要进一步研究来制定和检验药房之间的策略改善对这些患者亚组的药物同步服务登记推广。